Healthcare Affordability under Scrutiny: Insurers Face Congressional Hearings Amid Rising Costs
Washington D.C. – The nation’s largest health insurers are bracing for intense scrutiny as House Republicans prepare to hold hearings at the end of January addressing the escalating cost of healthcare and concerns over industry profits. This comes as political pressure mounts from both sides of the aisle, including a planned meeting between former President Donald Trump and insurance executives, to address affordability issues plaguing American families and employers.
insurers to Testify Before Congress
On January 22nd, the CEOs of UnitedHealth Group, CVS Health, Elevance Health, The Cigna Group, and Ascendiun (parent company of Blue Shield of California) will testify before both the House Committee on Energy and Commerce Subcommittee on Health and the House Committee on Ways and means according to a statement released on January 8th.The hearings, led by Ways and Means Committee Chairman jason Smith (R-Missouri) and Energy and Commerce Committee Chairman Brett Guthrie (R-Kentucky), will focus on the drivers of rising costs, the current state of healthcare affordability, and the role large health insurers play in the system.
political Pressure Mounts on Multiple Fronts
The congressional hearings are occurring alongside increased political attention on healthcare pricing. Former President Trump recently announced plans to meet with 14 insurers,directly criticizing their profitability and advocating for lower prices. “We’re trying to solve the healthcare problem. We’re trying to get better healthcare at a lower price,” Trump stated during a speech to House Republicans, further adding, “let the money go not to the big fat cats and the insurance companies that made 1,700% over the last short period of time. Let the money go directly to the people were they can buy their own healthcare.”
ACA Subsidies and the Threat of Premium Increases
The focus on insurance costs is notably acute following a period of uncertainty surrounding Affordable Care Act (ACA) subsidies. A government shutdown last year was triggered by a dispute over extending enhanced ACA subsidies, which expired at the end of 2025. The Kaiser Family Foundation (KFF) estimates that without these subsidies, the average annual premium for marketplace coverage will more than double, rising from $888 in 2025 to $1,904 in 2026.
While the House recently approved a three-year extension of the subsidies, its passage in the Senate remains uncertain. A bipartisan group of senators is currently working on a compromise to extend the subsidies for two years, signaling a continued effort to address affordability concerns.
Employer Costs Soar, Driven by Chronic Conditions and New medications
The burden of rising healthcare costs isn’t limited to individuals purchasing insurance through the ACA marketplaces. Employers are also facing significant increases in health benefit costs, with estimates suggesting a national average increase of nearly 10% in 2026 – the steepest rise in over a decade. Surveys indicate that these rising costs are largely attributed to several factors:
- Chronic and High-Cost Conditions: The increasing prevalence of chronic diseases like diabetes and heart disease drives up overall healthcare spending.
- Stop-Loss Claims: Higher numbers of expensive medical claims are impacting insurance payouts.
- Increased Care Utilization: More people are seeking medical care, contributing to increased demand and costs.
- Prescription Drug Spending: The cost of prescription drugs, particularly newer medications like GLP-1 receptor agonists used for diabetes and weight loss, is a major driver of rising expenses.
The Role of GLP-1 Medications
The surge in popularity and utilization of GLP-1 medications, such as Ozempic and Wegovy, is considerably impacting healthcare costs. While these drugs offer promising treatment options for diabetes and obesity, their high price tags are contributing to increased spending for both employers and insurers. The demand for these medications is expected to continue growing, potentially exacerbating cost pressures in the coming years.
Looking ahead: A Complex Landscape
The upcoming congressional hearings and ongoing political debate highlight the complex challenges facing the American healthcare system. Addressing affordability will require a multifaceted approach,potentially involving policy changes related to drug pricing,insurance regulations,and the ACA subsidies. The outcome of these discussions will have a profound impact on access to care and the financial well-being of millions of Americans.The industry will be closely watching to see how lawmakers navigate these challenges and what solutions emerge to address the escalating cost of healthcare.
